Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 12/2015

01-12-2015 | Capsule Commentary

Capsule Commentary on Dolan et al., The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients

Author: Victor O. Kolade, MD

Published in: Journal of General Internal Medicine | Issue 12/2015

Login to get access

Excerpt

Colorectal cancer (CRC) is one of the most prevalent cancers in the United States, and has several screening options. Unfortunately, screening rates have been suboptimal for years.1 For most screening modalities, colon preparation is not endearing, and screening is not yet fully reimbursed by insurance without provider referrals, as is the case for Pap smears, or without a provider visit at all, as with some nicotine replacement therapies. …
Literature
1.
Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening, incidence, and mortality—United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):884–889.
2.
Dolan NC, Ramirez-Zohfeld V, Rademaker AQ, Ferreira MR, Galanter WL, Radosta J, Eder M, Cameron KA. The effectiveness of a physician-only and physician-patient intervention on colorectal cancer screening discussions between providers and African American and Latino patients. J Gen Intern Med. 2015. doi:10.​1007/​s11606-015-3381-8.
3.
Sarkar U, Wachter RM, Schroeder SA, Schillinger D. Refocusing the lens: patient safety in ambulatory chronic disease care. Jt Comm J Qual Patient Saf. 2009;35(7):377–383.PubMed
4.
Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258–264.CrossRefPubMed
5.
Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, et al. Comparative Effectiveness of a Multifaceted Intervention to Improve Adherence to Annual Colorectal Cancer Screening in Community Health Centers. JAMA Intern Med. 2014;174(8):1235–1241.CrossRefPubMed
Metadata
Title
Capsule Commentary on Dolan et al., The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients
Author
Victor O. Kolade, MD
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3461-9

Other articles of this Issue 12/2015

Journal of General Internal Medicine 12/2015 Go to the issue

Original Research

Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients

Original Research

Medical School Experiences Associated with Change in Implicit Racial Bias Among 3547 Students: A Medical Student CHANGES Study Report

Capsule Commentary

Capsule Commentary on Chodos et al., Hospitalization-Associated Disability in Adults Admitted to a Safety Net Hospital

Original Research

The Association Between Sensemaking During Physician Team Rounds and Hospitalized Patients’ Outcomes

Capsule Commentary

Capsule Commentary on Chan et al., The Effect of a Care Transition Intervention on the Patient Experience of Older, Multi-lingual Adults in the Safety Net: Results of a Randomized Controlled Trial

Editorial

Medical Debates and Medical Reversal
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits